Opportunity Information: Apply for RFA MH 18 300
The National Institutes of Health (NIH) funding opportunity "Role of Myeloid Cells in Persistence and Eradication of HIV-1 Reservoirs from the Brain (R01)" (Funding Opportunity Number RFA-MH-18-300) supports research focused on how HIV-1 persists in myeloid cells within the central nervous system (CNS) and how that reservoir might be effectively targeted or eliminated. The core scientific emphasis is on understanding the mechanisms that allow HIV-1 to remain in the brain despite antiretroviral therapy, with particular attention to myeloid-lineage cells (for example, resident brain macrophages/microglia and related populations) that may serve as long-lived viral reservoirs. The FOA is designed to move the field forward on both basic biology (how persistence happens and is maintained) and translational strategies (how to intervene in ways that could reduce or clear these reservoirs and improve outcomes relevant to HIV-associated CNS complications).
The announcement makes clear that a broad range of approaches is welcome, spanning fundamental mechanistic studies through more application-oriented projects aimed at therapeutic targeting, eradication strategies, or other interventions that address viral persistence in the brain. Research may be conducted in domestic (U.S.-based) or international settings, reflecting NIH interest in globally relevant HIV science and the value of studying diverse cohorts, viral subtypes, clinical contexts, and research infrastructures. While the FOA encourages multidisciplinary teams and collaborative alliances, it does not require them, meaning a single lab or institution can apply if it has the necessary expertise and resources, but partnerships across disciplines (such as neurovirology, immunology, neuropathology, pharmacology, imaging, and clinical neuroscience) are explicitly viewed as beneficial for tackling this complex reservoir problem.
From a funding mechanism standpoint, this specific opportunity uses the NIH R01 grant mechanism, which is generally intended for well-developed research projects with a strong scientific premise and, in many cases, preliminary data that support feasibility. The companion FOA (RFA-MH-18-301) uses the R21 mechanism, which is typically better suited for exploratory, high-risk/high-reward projects, including concepts that may not yet have extensive preliminary data or projects that primarily leverage existing datasets. The FOA frames this distinction directly: applicants who have preliminary data and a more mature research plan may prefer the R01 route, while earlier-stage or more speculative ideas may be a better fit for the R21.
Eligibility is broad and inclusive, consistent with many NIH research announcements. Eligible applicants include various levels of government (state, county, city/township, and special district governments), independent school districts, and public housing authorities/Indian housing authorities. Academic institutions are eligible as well, including public and state-controlled institutions of higher education and private institutions of higher education. The FOA also welcomes applications from federally recognized Native American tribal governments and from Native American tribal organizations other than federally recognized tribal governments. Both nonprofit organizations (with or without 501(c)(3) status, and other than institutions of higher education) and for-profit organizations (other than small businesses) are eligible, alongside small businesses and other applicant types. In addition, the FOA highlights "Other Eligible Applicants" to underscore participation from Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISI), Historically Black Colleges and Universities (HBCUs), Hispanic-serving Institutions, Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, eligible federal agencies, regional organizations, U.S. territories or possessions, and non-domestic (non-U.S.) entities (foreign organizations). This explicit list signals NIH interest in broad engagement, including institutions that serve historically underrepresented populations and international partners who can contribute unique expertise, cohorts, and research settings.
Administratively, the opportunity is categorized as a discretionary grant under NIH, with activity areas tied to education and health, and it is associated with CFDA numbers 93.242, 93.279, and 93.853. The original closing date listed is 2017-09-06, and the record shows a creation date of 2017-05-01. While the summary provided does not specify an award ceiling or the expected number of awards, the central takeaway is that this FOA aims to accelerate progress toward understanding and ultimately addressing HIV persistence in brain myeloid cells, a key barrier to HIV cure strategies and an ongoing concern for neurological health in people living with HIV.Apply for RFA MH 18 300
- The National Institutes of Health in the education, health sector is offering a public funding opportunity titled "Role of Myeloid Cells in Persistence and Eradication of HIV-1 Reservoirs from the Brain (R01)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.242, 93.279, 93.853.
- This funding opportunity was created on 2017-05-01.
- Applicants must submit their applications by 2017-09-06. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Frequently Asked Questions (FAQs)
What is this NIH funding opportunity?
This is a National Institutes of Health (NIH) Funding Opportunity Announcement (FOA) titled "Role of Myeloid Cells in Persistence and Eradication of HIV-1 Reservoirs from the Brain (R01)." The Funding Opportunity Number is RFA-MH-18-300, and it uses the NIH R01 grant mechanism.
What is the main scientific focus of RFA-MH-18-300?
The FOA supports research on how HIV-1 persists in myeloid-lineage cells within the central nervous system (CNS) and how that brain reservoir might be effectively targeted or eliminated, including in the context of antiretroviral therapy.
Why does the FOA focus on myeloid cells in the brain?
The announcement emphasizes myeloid-lineage cells (such as resident brain macrophages and microglia and related populations) because they may serve as long-lived HIV-1 reservoirs in the CNS, contributing to viral persistence even when systemic virus is controlled by therapy.
What types of research approaches are encouraged under this FOA?
A broad range of approaches is welcomed, from fundamental mechanistic studies (how HIV-1 persistence happens and is maintained in the brain) to translational strategies (interventions aimed at therapeutic targeting, eradication strategies, or other approaches to reduce or clear CNS reservoirs).
Is this FOA limited to basic research, or can it include translational work?
It includes both. The FOA is designed to move the field forward on basic biology and on translational strategies intended to intervene in ways that could reduce or clear brain reservoirs and improve outcomes relevant to HIV-associated CNS complications.
Does the FOA specify the central barrier it is trying to address?
Yes. A key barrier highlighted is HIV persistence in brain myeloid cells despite antiretroviral therapy, which remains a major challenge for HIV cure strategies and for neurological health in people living with HIV.
Where can the research be conducted (U.S. only or international)?
Research may be conducted in domestic (U.S.-based) or international settings. NIH notes the value of globally relevant HIV science and the benefit of studying diverse cohorts, viral subtypes, clinical contexts, and research infrastructures.
Are multidisciplinary teams required?
No. The FOA encourages multidisciplinary teams and collaborative alliances, but they are not required. A single lab or institution can apply if it has the necessary expertise and resources.
What kinds of collaborations does NIH view as beneficial for this topic?
The FOA explicitly notes that partnerships across disciplines can be beneficial, including areas such as neurovirology, immunology, neuropathology, pharmacology, imaging, and clinical neuroscience.
What grant mechanism is used for this opportunity?
This opportunity uses the NIH R01 grant mechanism, which is generally intended for well-developed research projects with a strong scientific premise and often includes preliminary data supporting feasibility.
Is there a related or companion funding opportunity?
Yes. A companion FOA is mentioned: RFA-MH-18-301, which uses the R21 mechanism.
How does the R01 (this FOA) differ from the companion R21 FOA?
The FOA describes R01 as a better fit for applicants with preliminary data and a more mature research plan. The companion R21 is described as typically better suited for exploratory, high-risk/high-reward projects, including ideas that may not yet have extensive preliminary data or projects primarily leveraging existing datasets.
Who is eligible to apply?
Eligibility is broad. Eligible applicants include various levels of government (state, county, city/township, and special district governments), independent school districts, public housing authorities/Indian housing authorities, academic institutions (public/state-controlled and private institutions of higher education), federally recognized Native American tribal governments, and Native American tribal organizations other than federally recognized tribal governments.
Are nonprofits eligible to apply?
Yes. Nonprofit organizations are eligible, including those with or without 501(c)(3) status (other than institutions of higher education).
Are for-profit organizations eligible to apply?
Yes. For-profit organizations (other than small businesses) are listed as eligible, and small businesses are also included among eligible applicant types.
Does NIH explicitly encourage applications from certain institution types?
Yes. The FOA highlights "Other Eligible Applicants" to underscore broad participation, including Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISI), Historically Black Colleges and Universities (HBCUs), Hispanic-serving Institutions, Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, eligible federal agencies, regional organizations, U.S. territories or possessions, and non-domestic (non-U.S.) entities (foreign organizations).
Are foreign (non-U.S.) organizations eligible?
Yes. The FOA explicitly lists non-domestic (non-U.S.) entities (foreign organizations) among eligible applicants, and it also indicates that research may be conducted in international settings.
What is the nature of the award (grant type and agency category)?
The opportunity is categorized as a discretionary grant under NIH, with activity areas tied to education and health.
What CFDA numbers are associated with this opportunity?
The FOA is associated with CFDA numbers 93.242, 93.279, and 93.853.
What are the key dates listed in the summary?
The record shows a creation date of 2017-05-01, and the original closing date listed is 2017-09-06.
Does the provided summary state an award ceiling or the expected number of awards?
No. The summary provided does not specify an award ceiling or the expected number of awards.
What is the overall goal or intended impact of this FOA?
The central aim is to accelerate progress toward understanding and ultimately addressing HIV persistence in brain myeloid cells, supporting advances that could inform strategies to reduce or clear CNS reservoirs and improve outcomes relevant to HIV-associated CNS complications.
Browse more opportunities from the same category: Education, Health
Next opportunity: Enhancing Worker-Management Relations in Vietnam
Previous opportunity: Awards for Faculty
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA MH 18 300
Applicants also applied for:
Applicants who have applied for this opportunity (RFA MH 18 300) also looked into and applied for these:
| Funding Opportunity |
|---|
| Role of Myeloid Cells in Persistence and Eradication of HIV-1 Reservoirs from the Brain (R21) Apply for RFA MH 18 301 Funding Number: RFA MH 18 301 Agency: National Institutes of Health Category: Education, Health Funding Amount: $200,000 |
| Genomic Community Resources (U24) Apply for PAR 17 273 Funding Number: PAR 17 273 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| In Vitro and Animal Model Studies on HBV/HIV Co-Infection (R01) Apply for PA 17 280 Funding Number: PA 17 280 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| HIV and Hepatitis B Co-Infection: Advancing HBV Functional Cure through Clinical Research (R01) Apply for PA 17 279 Funding Number: PA 17 279 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Wearable to Track Recovery and Relapse Factors for People w/ Addiction(R43/R44) Apply for RFA DA 18 010 Funding Number: RFA DA 18 010 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Exploring Novel RNA Modifications in HIV/AIDS and Substance Use Disorders (R01) Apply for RFA DA 18 008 Funding Number: RFA DA 18 008 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Exploring Novel RNA Modifications in HIV/AIDS and Substance Use Disorders (R21) Apply for RFA DA 18 009 Funding Number: RFA DA 18 009 Agency: National Institutes of Health Category: Education, Health Funding Amount: $200,000 |
| In Vitro and Animal Model Studies on HBV/HIV Co-Infection (R21) Apply for PA 17 281 Funding Number: PA 17 281 Agency: National Institutes of Health Category: Education, Health Funding Amount: $200,000 |
| HIV and Hepatitis B Co-Infection: Advancing HBV Functional Cure through Clinical Research (R21) Apply for PA 17 278 Funding Number: PA 17 278 Agency: National Institutes of Health Category: Education, Health Funding Amount: $200,000 |
| Leveraging Population-based Cancer Registry Data to Study Health Disparities (R01) Apply for PA 17 289 Funding Number: PA 17 289 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Leveraging Population-based Cancer Registry Data to Study Health Disparities (R21) Apply for PA 17 288 Funding Number: PA 17 288 Agency: National Institutes of Health Category: Education, Health Funding Amount: $200,000 |
| Addressing Suicide Research Gaps: Aggregating and Mining Existing Data Sets for Secondary Analyses (R01) Apply for RFA MH 18 400 Funding Number: RFA MH 18 400 Agency: National Institutes of Health Category: Education, Health Funding Amount: $300,000 |
| Silencing of HIV-1 Proviruses (R61/R33) Apply for RFA AI 17 013 Funding Number: RFA AI 17 013 Agency: National Institutes of Health Category: Education, Health Funding Amount: $500,000 |
| U.S. Tobacco Control Policies to Reduce Health Disparities (R01) Apply for PAR 17 217 Funding Number: PAR 17 217 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| U.S. Tobacco Control Policies to Reduce Health Disparities (R21) Apply for PAR 17 218 Funding Number: PAR 17 218 Agency: National Institutes of Health Category: Education, Health Funding Amount: $200,000 |
| HIV/AIDS and the Tumor Niche (R01) Apply for RFA CA 17 030 Funding Number: RFA CA 17 030 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Addressing Suicide Research Gaps: Understanding Mortality Outcomes (R01) Apply for RFA MH 18 410 Funding Number: RFA MH 18 410 Agency: National Institutes of Health Category: Education, Health Funding Amount: $300,000 |
| Imaging the Persistent HIV Reservoir (R01) Apply for PA 17 305 Funding Number: PA 17 305 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| HIV/HCV Co-Infections in Substance Abusers (R01) Apply for PAS 17 311 Funding Number: PAS 17 311 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Limited Competition Cohort Studies of HIV/AIDS and Substance Abuse (U01) Apply for RFA DA 18 011 Funding Number: RFA DA 18 011 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA MH 18 300", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
